Literature DB >> 18375117

Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer.

A P Jones1, R Haynes, V Sauerzapf, S M Crawford, H Zhao, D Forman.   

Abstract

The aim was to examine the effect of geographical access to treatment services on cancer treatment patterns. Records for patients in northern England with breast, colon, rectal, lung, ovary and prostate tumours were augmented with estimates of travel time to the nearest hospital providing surgery, chemotherapy or radiotherapy. Using logistic regression to adjust for age, sex, tumour stage, selected tumour pathology characteristics and deprivation of place of residence, the likelihood of receiving radiotherapy was reduced for all sites studied with increasing travel time to the nearest radiotherapy hospital. Lung cancer patients living further from a thoracic surgery hospital were less likely to receive surgery, and both lung cancer and rectal cancer patients were less likely to receive chemotherapy if they lived distant from these services. Services provided in only a few specialised centres, involving longer than average patient journeys, all showed an inverse association between travel time and treatment take-up.

Entities:  

Mesh:

Year:  2008        PMID: 18375117     DOI: 10.1016/j.ejca.2008.02.001

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  49 in total

1.  Geographic influences on sexual and reproductive health service utilization in rural Mozambique.

Authors:  Jing Yao; Alan T Murray; Victor Agadjanian; Sarah R Hayford
Journal:  Appl Geogr       Date:  2011-08-10

2.  Cancer care urgently needs a real reform engine.

Authors:  Nick Bosanquet; Karol Sikora
Journal:  J R Soc Med       Date:  2009-01       Impact factor: 5.344

3.  Racial disparities in travel time to radiotherapy facilities in the Atlanta metropolitan area.

Authors:  Lucy A Peipins; Shannon Graham; Randall Young; Brian Lewis; Barry Flanagan
Journal:  Soc Sci Med       Date:  2013-04-29       Impact factor: 4.634

4.  Impact of travel time and rurality on presentation and outcomes of symptomatic colorectal cancer: a cross-sectional cohort study in primary care.

Authors:  Peninah Murage; Peter Murchie; Max Bachmann; Michael Crawford; Andy Jones
Journal:  Br J Gen Pract       Date:  2017-06-05       Impact factor: 5.386

5.  Readiness for Implementation of Lung Cancer Screening. A National Survey of Veterans Affairs Pulmonologists.

Authors:  Melissa H Tukey; Jack A Clark; Rendelle Bolton; Michael J Kelley; Christopher G Slatore; David H Au; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2016-10

6.  The Association Between Distances Traveled for Care and Treatment Choices for Pelvic Floor Disorders in a Rural Southwestern Population.

Authors:  Gena C Dunivan; Pamela S Fairchild; Sara B Cichowski; Rebecca G Rogers
Journal:  J Health Dispar Res Pract       Date:  2014

7.  Identification of underserved areas for urologic cancer care.

Authors:  Matthew Mossanen; Jason Izard; Jonathan L Wright; Jonathan D Harper; Michael P Porter; Kenn B Daratha; Sarah K Holt; John L Gore
Journal:  Cancer       Date:  2014-02-12       Impact factor: 6.860

8.  Travel of patients to distant hospitals for elective surgery in Japan: a cross-sectional analysis of a nationally representative sample.

Authors:  Kaname Yamamoto; Kiyohide Fushimi
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

9.  Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.

Authors:  Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Dawn L Hershman; Ahmedin Jemal; B Ashleigh Guadagnolo; James B Yu; Shane Hopkins; Michael Goldstein; Dean Bajorin; Sharon H Giordano; Michael Kosty; Anna Arnone; Amy Hanley; Stephanie Stevens; Christine Olsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-17       Impact factor: 7.038

10.  Social and geographical factors affecting access to treatment of lung cancer.

Authors:  S M Crawford; V Sauerzapf; R Haynes; H Zhao; D Forman; A P Jones
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.